1
0
0
Freelancermap
www.freelancermap.de
— Profil von Klaus-Peter Stengele aus Pleiskirchen, Senior Director Technology, CEO NimbleGen Systems GmbH, CEO and Co-founder, ...
Yachtclub Immenstaad
www.yci-online.de
Alegria, Florian TROEGER, Klaus-Peter STENGELE, Jörg MUNCK, Heiko WOLLMANN, BYCUEBodensee-Yacht-Club Überlingen e. V. Laden. Sponsor: Position, Familienname ...
Chemie Freelancer gesucht? - Top Experten von € / h
www.freelancermap.de
Klaus-Peter Stengele. verfügbar ... Freelancermap Twitter Freelancermap Facebook Freelancermap Instagram Freelancermap LinkedIn · Freelancermap logo. › freelancer-verzeichnis
Here - Affinomics
www.affinomics.org
Klaus-Peter Stengele: Profiling Antibody Recognition Patterns through NimbleGen Systems GmbH (a Roche affiliate), Germany. A universal ...
LinkedIn: Klaus-Peter Stengele | LinkedIn
Klaus-Peter Stengeles berufliches Profil anzeigen LinkedIn ist das weltweit größte ... Rare Reagents Centralised and Point of Care Solutions bei Roche Diagnostics ... The chemistry department of DNA-array company Nimblegen Systems Inc.
LinkedIn: Klaus-Peter Stengele – Pleiskirchen, Bayern, Deutschland - LinkedInde.linkedin.com › klaus-peter-stengele
Sehen Sie sich das Profil von Klaus-Peter Stengele auf LinkedIn an. Als weltweit größtes Business-Netzwerk hilft LinkedIn Menschen wie Klaus-Peter Stengele ...
LinkedIn: Klaus-Peter Stengele - Deutschland - LinkedIn
Aufgrund der robots.txt dieser Website ist keine Beschreibung für dieses Ergebnis verfügbar. Weitere Informationen
Klaus-Peter Stengele | LinkedInwww.linkedin.com › today › author
www.linkedin.com
Check out professional insights posted by Klaus-Peter Stengele, Senior Director Technology and Rare Reagents Centralised and Point of Care ...
lino Biotech verfügt dank fünf international renommierter ...
www.businesswire.com
— Dr. Klaus-Peter Stengele, Life-Science- und Diagnostikberater und Spezialist für Forschung, Entwicklung und Innovationsmanagement. › news › home
patentbuddy: Klaus-Peter Stengele
ROCHE NIMBLEGEN, INC., Pleiskirchen, DE
Senior Director Technology, CEO NimbleGen Systems GmbH ...
www.freelancermap.de
— Profil von Klaus-Peter Stengele aus Pleiskirchen, Senior Director Technology, CEO NimbleGen Systems GmbH, CEO and Co-founder, ... › profile › entwicklung
Klaus-Peter Stengele's Email & Phone - Roche Diagnostics ...contactout.com › Klaus-Peter-Stengele
contactout.com
Klaus-Peter Stengele's Email. Show email and phone number. Landshut Area, Germany. Leiter Nimblegen GmbH @ Roche Diagnostics.
Taylor & Francis Online
www.tandfonline.com
von KP Stengele · · Zitiert von: 7 — Isolation and Characterization of Diastereomeric 2′-Oeoxy-ribonucleoside-3′-phosphoramidites. Klaus-Peter Stengele Fakult#aUt fur Chemie, Universität ...
Klaus-Peter Stengele | Hoffmann-La Roche | 21 PublicationsAI Chat for scientific PDFs
typeset.io
Klaus-Peter Stengele is an academic researcher from Hoffmann-La Roche. The author has contributed to research in topics: Protecting group & Proteome. Klaus-Peter Stengele is an academic researcher from Hoffmann-La Roche. The author has contributed to research in topics: Protecting group & Proteome.
Automatisierte Oligonucleotidsynthese unter Verwendung...
openlibrary.org
Automatisierte Oligonucleotidsynthese unter Verwendung [beta]-eliminierbare Schutzgruppen by Klaus-Peter Stengele, 1991, Hartung-Gorre Verlag edition, in...
Wiley Online Library
onlinelibrary.wiley.com
von N Kretschy · · Zitiert von: 8 — Klaus-Peter Stengele,. Dr. Klaus-Peter Stengele. Roche Diagnostics, Penzberg (Deutschland). Search for more papers by this author · Prof. Mark M ...
Comparison of Methods for Photochemical Phosphoramidite ...
pubs.acs.org
von MC Pirrung · · Zitiert von: 111 — ... Veronika Somoza, Klaus-Peter Stengele, Mark M. Somoza. Express photolithographic DNA microarray synthesis with optimized chemistry and ... › doi
Klaus-Peter Stengele - Academia.eduindependent.academia.edu › KStengele
independent.academia.edu
Klaus-Peter Stengele studies Magnetic Properties, Small, and Magnetics.
ScienceDirect.com
www.sciencedirect.com
von KP Stengele · · Zitiert von: 81 — Klaus-Peter Stengele and Wolfgang Pfleiderer*. Fakultlt fir Chemie, Universitlt Konstanz, Postfach 5560, D Konstanz/West Germany. Abstract. The design of ...
Express photolithographic DNA microarray synthesis with optimized...
jnanobiotechnology.biomedcentral.com
... Somoza,; Klaus-Peter Stengele and; Mark M. SomozaEmail author by NimbleGen Systems GmbH (Waldkraiburg, Germany) and diluted ...
(PDF) Phosphorothioate analogs of 2',5'-oligoadenylate ...
www.researchgate.net
Klaus-Peter Stengele · Wolfgang Pfleiderer. The commonly used four 2′-deoxyribonucleoside-3′-(0-5-cyanoethyl, N-diisopropyl)-phosphoramidites have been ... ›
Bodensee YC Tops J/70 German Sailing League @ Kiel! - J/Boatsjboats.com › Blog
jboats.com
Klaus-Peter Stengele, Jonathan Koch and Joseph Pochhammer in Kiel. "The fact that we begin here as well and win in the end, we had not thought of. It was an up ...
Deutsche Segel-Bundesliga
deutsche-segelbundesliga.de
07 Jun Klaus-Peter Stengele. Klaus-Peter Stengele. Kategorien. 1. Segel-Bundesliga · 2. Segel-Bundesliga · ...
The Org
theorg.com
Klaus-Peter Stengele is a German chemist and entrepreneur who is currently an advisor at lino Biotech.
National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von KP Stengele · · Zitiert von: 19 — doi: ncn Authors. Klaus-Peter Stengele , Jochen Bühler, Sigrid Bühler, Evgueni Kvassiouk, Roland Green, Tamara Prykota, Wolfgang ...
Focal molography is a new method for the in situ analysis ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von V Gatterdam · · Zitiert von: 40 — Authors. Volker Gatterdam , Andreas Frutiger , Klaus-Peter Stengele , Dieter Heindl , Thomas Lübbers , Janos Vörös , Christof Fattinger ... von V Gatterdam · · Zitiert von: 40 — Authors. Volker Gatterdam , Andreas Frutiger , Klaus-Peter Stengele , Dieter Heindl , Thomas Lübbers , Janos Vörös , Christof Fattinger ...
yacht.de
www.yacht.de
— Klaus-Peter Stengele setzt sie auch bei seiner Selbstwendefock durch, „das kommt auf die Vorliekskurve an, manche Profile brauchen das“.
Aphrodite IOI
www.aphrodite101.com
— getroffen. 0 Kommentare | Kommentar schreiben. Kategorien: Klassenvereinigung. Keywords: Klaus-Peter, ...
Klaus-Peter Stengele | LinkedIn
www.linkedin.com
View Klaus-Peter Stengele's professional profile on LinkedIn and Rare Reagents Centralised and Point of Care Solutions bei Roche Diagnostics ... The chemistry department of DNA-array company Nimblegen Systems Inc. Improving ...
Klaus-Peter Stengele's Post
www.linkedin.com
View profile for Klaus-Peter Stengele. Klaus-Peter Stengele. Freelancer Life Science Consulting. 1y. Report this post; Close menu. Quite ... View profile for Klaus-Peter Stengele. Klaus-Peter Stengele. Freelancer Life Science Consulting. 1y. Report this post; Close menu. Quite ...
Klaus-Peter Stengele posted on LinkedInwww.linkedin.com › posts › klaus-peter-stengele _activity
www.linkedin.com
Es mag eine Fassade aus nachvollziehbaren Begruendungen geben, wenn man aber daran kratzt wirds schlimm ! Keinerlei Anstrengungen der Politik ...
Jordan Shlain, MD's Post - Blood Types & COVID
www.linkedin.com
Klaus-Peter Stengele. Freelancer Life Science Consulting. 3y. Report this comment; Close menu. it would only be expected ... Klaus-Peter Stengele. Freelancer Life Science Consulting. 3y. Report this comment; Close menu. it would only be expected ...
Michael Pirrung's Post
www.linkedin.com
Klaus-Peter Stengele. Freelancer Life Science Consulting. 1y. Report this comment; Close menu. Academic freedom, is it an ... Klaus-Peter Stengele. Freelancer Life Science Consulting. 1y. Report this comment; Close menu. Academic freedom, is it an ...
A method of cleaving labile functional groups from chemical ...
patents.google.com
Application filed by Chemogenix Gmbh, Klaus-Peter Stengele Publication of WO A Publication of WO A › patent
WO A3 - A method of cleaving labile functional groups ...www.google.com › patents
patents.google.com
Application filed by Chemogenix Gmbh, Klaus-Peter Stengele ... US B Roche Nimble Gen, Inc. Methods for synthesis of an ...
WO A1 - Tunneling junctions for sequencing Google...
patents.google.com
... Nikolaus Klaus-Peter STENGELE: Juraj Topolancik; Original Assignee: F. Hoffmann-La Roche Ag: Roche Diagnostics Gmbh: Roche Sequencing Solutions, Inc.
Klaus-Peter Stengele, Senior Director Technology, CEO NimbleGen ...www.freelancermap.com › freelancer-profiles › development › pr...
www.freelancermap.com
Mar 15, · Profile from Klaus-Peter Stengele from Pleiskirchen, Senior Director Technology, CEO NimbleGen Systems GmbH, CEO and Co-founder , projects ...
lino Biotech verfügt dank fünf international Yahoo Finanzen
de.finance.yahoo.com
— Dr. Klaus-Peter Stengele, Life-Science- und Diagnostikberater und Spezialist für Forschung, Entwicklung und Innovationsmanagement. › nachrichten › lino-biote...
Biotechnology in Bavaria PDF Free Download - DocPlayer.netdocplayer.net › Biotechnology-in-bavaria-...
docplayer.net
An example for the latter is Roche Diagnostics in Penzberg south of Munich. seed financing, because no other ... Dr. Klaus-Peter Stengele Beuthenerstr.
Express photolithographic DNA microarray synthesis with optimized ...www.ncbi.nlm.nih.gov › articles › PMC
www.ncbi.nlm.nih.gov
2 mrt · SPh-NPPOC phosphoramidites were manufactured by NimbleGen Systems GmbH ... Klaus-Peter Stengele, -sualk.
DIARYLSULFIDE BACKBONE CONTAINING PHOTOLABILE PROTECTING GROUPS -...
www.patentsencyclopedia.com
Inventors: Klaus-Peter Stengele (Pleiskirchen, DE) Assignees: NIMBLEGEN SYSTEMS GMBH IPC8 Class: AC40B5018FI USPC Class:
Alle Infos zum Namen "Peter Stengele"
sortiert nach Relevanz / Datum